
Dermata Therapeutics, Inc.
DRMANasdaqCIK 1853816HealthcareFiscal year ends Dec 31
Reports and events: 135 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2025-01-2108:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-25-000570 |
| 2024-11-1418:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-24-014289 |
| 2024-11-1316:16 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001654954-24-014274 |
| 2024-09-1717:25 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-012031 |
| 2024-08-0716:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-24-010104 |
| 2024-08-0716:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001654954-24-010103 |
| 2024-08-0217:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-009903 |
| 2024-06-0717:11 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001654954-24-007532 |
| 2024-06-0509:02 ET | 8-K | 8.01 Other events | 0001654954-24-007369 |
| 2024-05-2416:06 ET | 8-K | 3.01 Delisting notice | 0001654954-24-006912 |
| 2024-05-1716:09 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001654954-24-006608 |
| 2024-05-1516:07 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001654954-24-006398 |
| 2024-05-1516:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-24-006396 |
| 2024-05-1509:00 ET | 8-K | 3.01 Delisting notice; 8.01 Other events | 0001654954-24-006312 |
| 2024-05-1409:16 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001654954-24-006133 |
| 2024-05-0717:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001654954-24-005715 |
| 2024-03-2616:26 ET | DEF 14A | Proxy statementPeriod 2024-03-05 | 0001654954-24-003656 |
| 2024-03-2116:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001654954-24-003501 |
| 2024-03-2116:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-24-003500 |
| 2024-01-1216:06 ET | 8-K | 5.07 Shareholder vote results | 0001654954-24-000520 |
| 2023-12-0817:29 ET | DEF 14A | Proxy statementPeriod 2023-12-07 | 0001654954-23-015300 |
| 2023-11-1716:06 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001654954-23-014542 |
| 2023-11-1618:16 ET | 8-K | 3.01 Delisting notice | 0001654954-23-014446 |
| 2023-11-0916:09 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001654954-23-014016 |
| 2023-11-0916:08 ET | 8-K | 2.02 Results of operations; 4.01 Change of auditor; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-23-014015 |
| 2023-08-1016:18 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-23-010489 |
| 2023-08-1016:16 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001654954-23-010487 |
| 2023-08-0316:31 ET | 8-K | 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001654954-23-010092 |
| 2023-07-0716:21 ET | S-1 | Registration statement | 0001654954-23-008945 |
| 2023-06-2316:19 ET | DEF 14A | Proxy statementPeriod 2023-08-03 | 0001654954-23-008352 |
| 2023-05-2417:13 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-23-007177 |
| 2023-05-1116:07 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001654954-23-006208 |
| 2023-05-1116:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-23-006209 |
| 2023-03-3116:06 ET | SC 13D/A | Ownership report, active investor, amended | 0001654954-23-004104 |
| 2023-03-3016:06 ET | SC 13D/A | Ownership report, active investor, amended | 0001654954-23-003923 |
| 2023-03-2817:28 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001654954-23-003730 |
| 2023-03-2816:06 ET | 8-K | 8.01 Other events | 0001654954-23-003722 |
| 2023-03-2016:36 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-23-003181 |
| 2023-03-1609:22 ET | S-1/A | Registration statement, amended | 0001654954-23-002967 |
| 2023-03-1519:53 ET | S-1/A | Registration statement, amended | 0001654954-23-002876 |
| 2023-03-1317:07 ET | S-1/A | Registration statement, amended | 0001654954-23-002742 |
| 2023-03-1313:16 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001654954-23-002711 |
| 2023-03-0117:05 ET | S-1 | Registration statement | 0001654954-23-002273 |
| 2023-02-2116:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-23-001927 |
| 2023-02-2116:10 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001654954-23-001926 |
| 2023-02-0816:05 ET | 8-K | 5.07 Shareholder vote results | 0001654954-23-001476 |
| 2023-01-1817:01 ET | SC 13D/A | Ownership report, active investor, amended | 0001654954-23-000567 |
| 2023-01-1308:00 ET | DEF 14A | Proxy statementPeriod 2023-01-11 | 0001654954-23-000377 |
| 2022-12-1516:05 ET | 8-K | 3.01 Delisting notice; 8.01 Other events | 0001654954-22-016569 |
| 2022-12-0509:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-22-016099 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 00:26 ET. Listed shows no prices and gives no investment advice.